Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Technology Times New Jersey.
Press releases published on August 20, 2025
StorageBlue Appoints Matt Mrowicki as Chief Technology Officer to Drive Innovation in Self-Storage Industry
StorageBlue focuses on automation, AI, and innovative digital solutions designed to deliver unmatched convenience and value to tenants. ENGLEWOOD CLIFFS, NJ, UNITED STATES, August 20, 2025 /EINPresswire.com/ -- StorageBlue, the brainchild of E! …
One-of-a-Kind Limb-Sparing Surgery Provides New Hope for Pediatric Osteosarcoma Patients
Dr. James C. Wittig and Team Pioneer Breakthrough Surgical Approach Using 3D-Printed Prosthesis and Free Vascularized Fibula Transplant MORRISTOWN, NJ, UNITED STATES, August 20, 2025 /EINPresswire.com/ -- Dr. James C. Wittig, one of the world's top …
Public Safety Technology Company Launches Free Tool to Assess and Strengthen Community Outcomes
New assessment helps agencies benchmark key areas like stakeholder engagement, data access, and response strategy. CHERRY HILL, NJ, UNITED STATES, August 20, 2025 /EINPresswire.com/ -- Simsi, a global public safety technology company that specializes in …
Office Technology Leaders from HP, Ricoh, & Nexera Discuss AI, Digital Transformation, and Attracting New Talent
The Cannata Report's Women Influencers Share Insights on the Reshaping of the Office Tech Dealer Channel in New Video HAMBURG, NJ, UNITED STATES, August 20, 2025 /EINPresswire.com/ -- The Cannata Report has released a new video featuring candid insights …
Ascentage Pharma Reports 2025 Interim Unaudited Six Months Financial Results and Business Updates
Product sales from Olverembatinib in the first half of 2025 increased 93% year-over-year to US$30.3 million (RMB217.4 million), primarily attributable to the expansion of NRDL coverage Commenced commercial sales of Lisaftoclax in China, following approval …
Global Enzymes Market Set to Reach $20.4 Billion by 2029 | Asia-Pacific Emerges as a Hotspot
Delray Beach, FL, Aug. 20, 2025 (GLOBE NEWSWIRE) -- According to MarketsandMarkets, the global enzymes market is experiencing robust growth, driven by innovations in biotechnology, increasing demand in biopharmaceutical production, and rising environmental …
NowVertical Group Announces Second Quarter 2025 Earnings Release Date and Financial Update Webinar
TORONTO, Aug. 20, 2025 (GLOBE NEWSWIRE) -- NowVertical Group Inc. (TSXV: NOW) (“NowVertical” or the “Company”), a leading data and AI solutions provider, will announce its 2025 second quarter results after the market close on Wednesday, August 27, 2025. …
Inventronics Announces 2025 Q2 Financial Results
CALGARY, Alberta, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Inventronics Limited (the “Corporation”) (IVX:TSX Venture), a designer and manufacturer of enclosures for the telecommunications, cable, electric distribution, energy, and other industries in Canada and …
Larkspur Biosciences Announces Discovery of LRK-4189, a First-in-Class Degrader of the Lipid Kinase PIP4K2C, for the Treatment of Microsatellite Stable (MSS) Colorectal Cancer at the ACS Fall 2025 Meeting
CAMBRIDGE, Mass., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Larkspur Biosciences, a company pioneering a new wave in cancer therapy that destroys tumors by targeting cancer cell fitness, today announced the discovery of LRK-4189, a first-in-class degrader of the …
BioAge Labs to Present at Upcoming Investor Conferences
EMERYVILLE, Calif., Aug. 20, 2025 (GLOBE NEWSWIRE) -- BioAge Labs, Inc. (NASDAQ: BIOA) ("BioAge", "the Company"), a clinical-stage biotechnology company developing therapeutic product candidates for metabolic diseases by targeting the biology of human …
iRhythm Technologies to Participate in Upcoming Investor Conferences
SAN FRANCISCO, Aug. 20, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict disease, today announced that its management team is …
Onco360® Has Been Selected as a Specialty Pharmacy Partner for HERNEXEOS® (zongertinib)
LOUISVILLE, K.Y., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Onco360®, the nation’s leading independent Specialty Pharmacy, has been selected as a pharmacy partner by Boehringer Ingelheim for Hernexeos® (Zongertinib). The Food and Drug Administration approved …
BlackLine Announces Participation in Upcoming Investor Conference
LOS ANGELES, Aug. 20, 2025 (GLOBE NEWSWIRE) -- BlackLine, Inc. (Nasdaq: BL) today announced that BlackLine’s management team will participate in the following upcoming investor conference: Citi’s 2025 Global TMT Conference Wednesday, September 3, 2025 …
3D Systems Announces Chief Financial Officer Transition
3D Systems’ Executive Vice President, Phyllis Nordstrom to Serve as Interim Chief Financial Officer ROCK HILL, S.C., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Today, 3D Systems (NYSE: DDD) announced that Jeffrey D. Creech is stepping down as the company’s Chief …
Astera Labs Announces Third Quarter 2025 Financial Conference Participation
SAN JOSE, Calif., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Astera Labs, Inc. (Nasdaq: ALAB), a leader in semiconductor-based connectivity solutions for rack-scale AI infrastructure, today announced its participation in financial conferences for the third quarter …
Sana Biotechnology Announces Closing of Full Exercise of Underwriters’ Option to Purchase Additional Shares
SEATTLE, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (Nasdaq: SANA) (“Sana”), a company focused on changing the possible for patients through engineered cells, today announced that it has closed the sale of 3,358,208 shares of its common …
TruGolf Reports Second Quarter 2025 Financial Results Q2 2025 Sales Grow 11.3% Over Q2 2024
Salt Lake City, Utah, Aug. 20, 2025 (GLOBE NEWSWIRE) -- TruGolf Holdings, Inc. (NASDAQ: TRUG), a leading provider of golf simulator software and hardware, announced today its second quarter 2025 results. The Company reported sales of $4.3 million, up 11.3% …
NurExone Biologic Announces Preclinical Evidence of Structural Repair in Injured Spinal Cord Tissue following ExoPTEN Treatment
TORONTO and HAIFA, Israel, Aug. 20, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”) is pleased to announce new preclinical imaging results providing anatomical evidence consistent with …
Rhythm Pharmaceuticals Announces FDA Acceptance of sNDA for Setmelanotide in Acquired Hypothalamic Obesity
– U.S. Food and Drug Administration accepts sNDA for filing with priority review; sets PDUFA goal date of December 20, 2025 -- – European Medicines Agency accepts and validates submission for Type II variation MAA for setmelanotide to treat acquired …
Invivyd Announces Proposed Public Offering of Common Stock
WALTHAM, Mass., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Invivyd) (Nasdaq: IVVD) today announced that it has commenced an underwritten public offering of shares of its common stock. In addition, Invivyd intends to grant the underwriters an option …